OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-4.78%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$500M
AUM Growth
+$500M
(-18%)
Cap. Flow
-$46.6M
Cap. Flow
% of AUM
-9.33%
Top 10 Holdings %
Top 10 Hldgs %
94.09%
Holding
22
New
2
Increased
5
Reduced
8
Closed
1
Top Buys
| 1 |
BIOL
Biolase, Inc.
BIOL
|
$5.35M |
| 2 |
Soleno Therapeutics
SLNO
|
$4.3M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$2.59M |
| 4 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$2.21M |
| 5 |
ELGX
Endologix Inc
ELGX
|
$1.94M |
Top Sells
| 1 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$47.8M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$11.5M |
| 3 |
AXDX
Accelerate Diagnostics
AXDX
|
$2.34M |
| 4 |
QuidelOrtho
QDEL
|
$1.6M |
| 5 |
Pacific Biosciences
PACB
|
$615K |
Sector Composition
| 1 | Healthcare | 86.27% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
| $121M | 24.04% |
4,617,337
-89,300
| -2% | -$2.34M |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $104M | 20.57% |
2,388,548
-36,868
| -2% | -$1.6M |
|
|
TSRO
3
DELISTED
TESARO, Inc.
TSRO
| $73.7M | 14.64% |
891,242
-139,583
| -14% | -$11.5M |
|
|
MZOR
4
DELISTED
Mazor Robotics Ltd.
MZOR
| $66.7M | 13.25% |
1,292,776
-927,024
| -42% | -$47.8M |
|
|
AMRN
5
Amarin Corp
AMRN
$311M
| $25.3M | 5.02% |
6,303,307
| – | – |
|
|
6
Pacific Biosciences
PACB
$393M
| $22.3M | 4.43% |
8,453,375
-233,080
| -3% | -$615K |
|
|
VRML
7
DELISTED
Vermillion, Inc.
VRML
| $19M | 3.77% |
9,825,289
| – | – |
|
8
Opko Health
OPK
$1.1B
| $18.8M | 3.73% |
3,826,760
+190,000
| +5% | +$931K |
|
|
BIOL
9
DELISTED
Biolase, Inc.
BIOL
| $13.2M | 2.61% |
30,866,262
+12,545,612
| +68% | +$5.35M |
|
|
ADAP
10
Adaptimmune Therapeutics
ADAP
$15.6M
| $6.9M | 1.37% |
1,032,721
+330,860
| +47% | +$2.21M |
|
|
AGEN
11
Agenus
AGEN
$133M
| $5.04M | 1% |
1,547,392
-50,000
| -3% | -$163K |
|
|
ARNA
12
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.78M | 0.95% |
140,666
+76,293
| +119% | +$2.59M |
|
|
EPZM
13
DELISTED
Epizyme, Inc
EPZM
| $4.55M | 0.9% |
362,892
-6,511
| -2% | -$81.7K |
|
|
14
Soleno Therapeutics
SLNO
$3.6B
| $4.3M | 0.85% |
+2,388,060
| New | +$4.3M |
|
|
CFRX
15
DELISTED
ContraFect Corporation
CFRX
| $2.93M | 0.58% |
2,900,417
+718,385
| +33% | +$725K |
|
16
Precigen
PGEN
$1.34B
| $2.25M | 0.45% |
195,000
| – | – |
|
17
Biogen
BIIB
$19.4B
| $2.03M | 0.4% |
6,368
| – | – |
|
|
ELGX
18
DELISTED
Endologix Inc
ELGX
| $1.94M | 0.39% |
+362,727
| New | +$1.94M |
|
19
Accuray
ARAY
$157M
| $1.62M | 0.32% |
376,799
-96,457
| -20% | -$415K |
|
20
Vivani Medical
VANI
$68.1M
| $97K | 0.02% |
50,804
| – | – |
|
21
AquaBounty Technologies
AQB
$4.58M
| – | – |
-12,204
| Closed | -$87K |
|
|
NXTM
22
DELISTED
NxStage Medical Inc.
NXTM
| – | – |
0
| – | – |
|